Koers Aurora Cannabis Inc Toronto S.E.
Aandelen
CA7561027037
Farmaceutische producten
Omzet 2024 * | 272 mln. 199 mln. 186 mln. | Omzet 2025 * | 320 mln. 234 mln. 219 mln. | Marktkapitalisatie | 501 mln. 366 mln. 343 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -61 mln. -44,59 mln. -41,73 mln. | Nettowinst (verlies) 2025 * | -7 mln. -5,12 mln. -4,79 mln. | EV/omzet 2024 * | 1,84 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,57 x |
K/w-verhouding 2024 * |
-5,87
x | K/w-verhouding 2025 * |
-56,6
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Aurora Cannabis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 52 | 06-07-20 |
Simona King
DFI | Director of Finance/CFO | 52 | 21/02 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Funk
CHM | Chairman | 67 | 25-07-18 |
Michael Singer
BRD | Director/Board Member | 60 | 20-05-16 |
Adam Szweras
BRD | Director/Board Member | 52 | 10-08-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
+0,09% | 1,65 mld. | |
-12,97% | 1,53 mld. |